J9269 Injection. tagraxofusp-erzs 10 micrograms
Also known as: tagraxofusp, Elzonris
Injection of tagraxofusp-erzs, 10 microgram. An interleukin-3 fused to diphtheria toxin used for cutaneous and systemic mastocytosis.
In Plain Language
mast cell cancer injection; rare cancer treatment
Clinical Context
Used for blastic plasmacytoid dendritic cell neoplasm and mastocytosis. Targeted therapy for rare hematologic malignancies expressing CD123.
RVU Information
CPT J9269 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9269?
CPT J9269 (Injection. tagraxofusp-erzs 10 micrograms) is a J Codes (Drugs) code. Injection of tagraxofusp-erzs, 10 microgram. An interleukin-3 fused to diphtheria toxin used for cutaneous and systemic mastocytosis.
How is J9269 administered?
CPT J9269 is administered by a healthcare provider, typically via injection or infusion. Used for blastic plasmacytoid dendritic cell neoplasm and mastocytosis. Targeted therapy for rare hematologic malignancies expressing CD123. It is used by Oncology, Hematology, Dermatology.
When is CPT J9269 used?
Used for blastic plasmacytoid dendritic cell neoplasm and mastocytosis. Targeted therapy for rare hematologic malignancies expressing CD123.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.